The nation of Zimbabwe has rejected a substantial US healthcare agreement valued at $367m (272 million pounds) over five years due to the United States' demand for confidential information.
This rejection became public after a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesman later clarified that the US was demanding access to genetic material for research and commercial purposes while was unwilling to share the benefits from future treatments.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for continued talks to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Implications
This development comes after a similar case in Kenya, where a court blocked a related deal with the US following legal challenges were filed about the safety of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral agreements to enhance openness and accountability.
According to statements, 16 African countries have to date signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Put simply, our nation would supply the raw materials for scientific discovery with no assurance that the final treatments would be available to our people should a future health crisis arise."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems already set up through the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This mechanism is designed to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to ongoing dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and interests of both nations."
Medical Community Reaction
Medical experts expressed it acknowledged the official position, but urged that negotiations should continue since a large portion of the country's Aids initiatives depended on international support.
"Where specific concerns arise, including those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it added.
The halted deal highlights the ongoing tensions between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more data-driven world.